Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.19.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2019
Stockholders' Equity Note [Abstract]  
Schedule of private placements of securities pursuant to unit purchase agreements and subscription agreements
Date of closing   Common Stock Issued     Warrants issued     Unit Price     Net proceeds  
October 12, 2018     2,004,106       1,302,669     $ 0.90     $ 1,630,991  
October 18, 2018     1,640,334       1,066,218     $ 0.90     $ 1,287,007  
November 2, 2018     1,499,456       974,645     $ 0.90     $ 1,215,242  
December 5, 2018     1,338,775       870,200     $ 0.90     $ 1,083,307  
February 12, 2019     805,554       523,610     $ 0.90     $ 725,000  
                                 
Total     7,288,225       4,737,342             $ 5,941,547  
Schedule of changes in options outstanding
    Number
of
Options
    Weighted Average Exercise Price For Share     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic
Value
 
Outstanding and expected to vest at June 30, 2018     3,068,865     $ 1.45       8.8     $ 511,000  
Forfeited     (25,625 )   $ 7.59       -     $ -  
Issued     2,700,000     $ 1.15       9.7     $ 1,674,000  
Outstanding and expected to vest at March 31, 2019     5,743,240     $ 1.28       8.9     $ 4,199,110  
Options exercisable at March 31, 2019     1,278,687     $ 2.22       7.6     $ 799,763  
Schedule of changes in outstanding warrants
    Number of Shares     Weighted Average Exercise Price Per Share  
Outstanding and vested at June 30, 2018     9,815,025     $ 3.96  
Forfeited     (7,500 )     4.00  
Issued     6,240,247       1.46  
Outstanding and vested at March 31, 2019     16,047,772     $ 2.15  
Schedule of stock-based compensation expense
    Nine months ended March 31,
2019
    Nine months ended March 31,
2018
 
Research and development   $ 65,700     $ 44,500  
General and administrative     744,800       320,700  
Total   $ 810,500     $ 365,200